Articles by Antonella D'Arminio Monforte

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

Worm, Signe W; Friis-Møller, Nina; Bruyand, Mathias; More

AIDS. 24(3):427-435, January 28th, 2010.

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

Mussini, Cristina; Manzardo, Christian; Johnson, Margaret; More

AIDS. 22(18):2461-2469, November 30th, 2008.

Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy

Marchetti, Giulia; Bellistrì, Giusi M; Borghi, Elisa; More

AIDS. 22(15):2035-2038, October 1st, 2008.

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy

Zanone Poma, Barbara; Riva, Agostino; Nasi, Milena; More

AIDS. 22(14):1769-1778, September 12th, 2008.

Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

Bannister, Wendy P; Ruiz, Lidia; Cozzi-Lepri, Alessandro; More

AIDS. 22(3):367-376, January 30th, 2008.

Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

Cicconi, Paola; Cozzi-lepri, Alessandro; Phillips, Andrew; More

AIDS. 21(5):599-606, March 12th, 2007.

Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART

Marchetti, Giulia; Gori, Andrea; Casabianca, Anna; More

AIDS. 20(13):1727-1736, August 22nd, 2006.

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure

Ceccherini-Silberstein, Francesca; Erba, Fulvio; Gago, Federico; More

AIDS. 18(12):11-19, August 20th, 2004.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS. 18(2):227-235, January 23rd, 2004.

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

Friis-Møller, Nina; Weber, Rainer; Reiss, Peter; More

AIDS. 17(8):1179-1193, May 23rd, 2003.

Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase...

Dorrucci, Maria; Pezzotti, Patrizio; Grisorio, Benvenuto; More

AIDS. 15(13):1733-1736, September 7th, 2001.

Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy

De Luca, Andrea; Giancola, Maria Letizia; Ammassari, Adriana; More

AIDS. 14(14):F117-F121, September 29th, 2000.

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

Monforte, Antonella d'Arminio; Lepri, Alessandro Cozzi; Rezza, Giovanni; More

AIDS. 14(5):499-507, March 31st, 2000.

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

Monforte, Antonella d'Arminio; Testa, Letizia; Adorni, Fulvio; More

AIDS. 12(13):1631-1637, September 10th, 1998.

Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients

Cinque, Paola; Vago, Luca; Dahl, Helena; More

AIDS. 10(9):951-958, 1996.